Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of "Moderate Buy" by Brokerages

Stevanato Group logo with Medical background

Key Points

  • Stevanato Group S.p.A. (NYSE:STVN) has received an average analyst recommendation of "Moderate Buy", with ratings from six firms including two holds and one strong buy.
  • Institutional investors have significantly increased their stakes in Stevanato Group, with Bessemer Group raising its holdings by 14,623.3% in the first quarter alone.
  • As of now, Stevanato Group's stock price is €22.48, with a market capitalization of $6.81 billion and a PE ratio of 41.63.
  • Need better tools to track Stevanato Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six research firms that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company.

Separately, William Blair reiterated an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th.

Read Our Latest Analysis on Stevanato Group

Stevanato Group Price Performance

STVN traded down €0.33 on Wednesday, reaching €22.52. The company had a trading volume of 336,900 shares, compared to its average volume of 339,336. The business has a 50 day simple moving average of €24.34 and a 200 day simple moving average of €22.49. The company has a market cap of $6.82 billion, a price-to-earnings ratio of 41.70, a P/E/G ratio of 2.16 and a beta of 0.55. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79. Stevanato Group has a 52-week low of €17.12 and a 52-week high of €28.00.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Conestoga Capital Advisors LLC lifted its position in Stevanato Group by 1.3% during the 1st quarter. Conestoga Capital Advisors LLC now owns 8,189,926 shares of the company's stock valued at $167,238,000 after acquiring an additional 106,930 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in Stevanato Group by 13.3% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company's stock valued at $76,468,000 after acquiring an additional 439,722 shares during the period. TimesSquare Capital Management LLC lifted its position in Stevanato Group by 2.1% during the 1st quarter. TimesSquare Capital Management LLC now owns 3,358,966 shares of the company's stock valued at $68,590,000 after acquiring an additional 70,437 shares during the period. Artisan Partners Limited Partnership boosted its stake in Stevanato Group by 20.0% in the 2nd quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company's stock worth $66,786,000 after purchasing an additional 455,323 shares in the last quarter. Finally, Bamco Inc. NY boosted its stake in Stevanato Group by 2.1% in the 2nd quarter. Bamco Inc. NY now owns 1,888,050 shares of the company's stock worth $46,125,000 after purchasing an additional 39,528 shares in the last quarter.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines